Vivoryon Therapeutics NV
AEX:VVY
Vivoryon Therapeutics NV
AEX:VVY
Price:
1.384
EUR
1.91%
Market Closed
Market Cap:
€41m
Vivoryon Therapeutics NV
Other
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
Vivoryon Therapeutics NV
Other Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Vivoryon Therapeutics NV
AEX:VVY
|
Other
€0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
BioNTech SE
NASDAQ:BNTX
|
Other
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
CureVac NV
NASDAQ:CVAC
|
Other
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Immatics NV
NASDAQ:IMTX
|
Other
-€7m
|
CAGR 3-Years
4%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
Biotest AG
XETRA:BIO
|
Other
-€40.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Formycon AG
XETRA:FYB
|
Other
-€42.2m
|
CAGR 3-Years
-472%
|
CAGR 5-Years
-331%
|
CAGR 10-Years
-137%
|
|
No Stocks Found
Vivoryon Therapeutics NV
Glance View
The company is headquartered in Halle, Sachsen-Anhalt and currently employs 16 full-time employees. The company went IPO on 2014-10-27.
VVY
Intrinsic Value
Not Available
See Also
What is Vivoryon Therapeutics NV's Other?
Other
0
EUR
0
EUR
Based on the financial report for Dec 31, 2024, Vivoryon Therapeutics NV's Other amounts to 0 EUR.
